Painchek Ltd (PCK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Painchek Ltd (PCK) has a cash flow conversion efficiency ratio of 1.892x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.11 Million ≈ $-1.49 Million USD) by net assets (AU$-1.11 Million ≈ $-787.47K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Painchek Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Painchek Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Painchek Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Painchek Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Painchek Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
K-Tech Solutions Company Limited Class A Ordinary Shares
NASDAQ:KMRK
|
N/A |
|
Tips Films Limited
NSE:TIPSFILMS
|
0.011x |
|
Desert Control AS
OL:DSRT
|
-0.415x |
|
Green Packet Bhd
KLSE:0082
|
0.221x |
|
Scan Inter PCL
BK:SCN
|
0.030x |
|
Zhongchao Inc
NASDAQ:ZCMD
|
0.077x |
|
Huddlestock Fintech As
OL:HUDL
|
-0.127x |
|
JPMorgan Emerging Markets Ord
LSE:JMG
|
0.007x |
Annual Cash Flow Conversion Efficiency for Painchek Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Painchek Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Painchek Ltd (PCK) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$-1.11 Million ≈ $-787.47K |
AU$-6.75 Million ≈ $-4.78 Million |
6.068x | +209.86% |
| 2024-06-30 | AU$1.29 Million ≈ $913.02K |
AU$-7.13 Million ≈ $-5.04 Million |
-5.524x | +41.63% |
| 2023-06-30 | AU$668.13K ≈ $472.75K |
AU$-6.32 Million ≈ $-4.47 Million |
-9.463x | -552.31% |
| 2022-06-30 | AU$4.82 Million ≈ $3.41 Million |
AU$-7.00 Million ≈ $-4.95 Million |
-1.451x | -190.23% |
| 2021-06-30 | AU$8.24 Million ≈ $5.83 Million |
AU$-4.12 Million ≈ $-2.92 Million |
-0.500x | -9.38% |
| 2020-06-30 | AU$4.13 Million ≈ $2.92 Million |
AU$-1.89 Million ≈ $-1.33 Million |
-0.457x | +38.75% |
| 2019-06-30 | AU$4.12 Million ≈ $2.92 Million |
AU$-3.07 Million ≈ $-2.18 Million |
-0.746x | +17.40% |
| 2018-06-30 | AU$3.22 Million ≈ $2.28 Million |
AU$-2.91 Million ≈ $-2.06 Million |
-0.903x | -42.13% |
| 2017-06-30 | AU$2.48 Million ≈ $1.76 Million |
AU$-1.58 Million ≈ $-1.12 Million |
-0.636x | -123.79% |
| 2016-06-30 | AU$-914.86K ≈ $-647.32K |
AU$-2.44 Million ≈ $-1.73 Million |
2.671x | +19529.85% |
| 2011-06-30 | AU$164.24K ≈ $116.21K |
AU$-2.26K ≈ $-1.60K |
-0.014x | -- |
About Painchek Ltd
PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate th… Read more